Scotland approves Epidyolex for tuberous sclerosis-related epilepsy

Cannabis Health News

Estimated reading time: 2 minutes Scotland’s health bosses have given the green light for Epidyolex to be prescribed on the NHS for epilepsy-related tuberous sclerosis complex (TSC). The Scottish Medicines Consortium, the body responsible for deciding which drugs will be available through the NHS, has recommended Epidyolex to treat people living with TSC aged two years and over. Tuberous Sclerosis Complex (TSC) is a rare genetic condition, which causes non-cancerous growths to develop around the body, such as the brain, eyes, heart and skin. It is estimated that there are between 3,700 and 11,000 patients in the UK living with TSC. Jazz Pharmaceuticals, which took over Epidyolex manufacturer GW Pharma last year, announced it had ​received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) in August, for the drug to be used as an adjunctive treatment for the condition. Last month, Wales  approved the medicine for use on the NHS, and NICE has begun appraising it for use in England, with a decision expected later in 2022. Epidyolex, a purified cannabidiol (CBD) treatment, is already available through the NHS to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome.  The Tuberous Sclerosis Association said it was “delighted” with the decision and that Epidyolex offers an important option in the treatment and management of TSC-related epilepsy which can be hard to treat with common epilepsy medicines. Chief executive Louise Fish, commented: “We’re delighted that the SMC has recommended Epidyolex for TSC-refractory epilepsy. TSC-related epilepsy is often hard to treat and it has a huge impact on day-to-day living for people with TSC and their families. Access to Epidyolex in Scotland could have major benefits for those living with TSC in the nation. Thank you to everyone in the TSC community who shared their experience of taking this drug with…

Excerpt only …
READ MORE BELOW
Source : Scotland approves Epidyolex for tuberous sclerosis-related epilepsy

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.